5-Methyl-[1,4]diazepane, 95.0%, 500mg

2-butyl-3-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, 95%, 100g

Methyl 2-amino-5-(trifluoromethyl)benzoate, 98.0%, 10g

2-Phenoxytetrahydropyran>90.0%(GC)5mL

(1S)-2′-[[Bis(1-methylethyl)amino]carbonyl][1,1′-binaphthalene]-2-carboxylic acid, 250mg

4-Acetamido-3-hydroxybenzoic acid, 95.0%, 2g

N,N-Dibenzyl-2-aminoethanol, 95.0%, 1g

Mercury(II) iodide, min. 99%, PA, ACS, red, 500 g, plastic packaging.

4-(2-Cyanoacetyl)benzonitrile, 95+%, 5g

(R)-1-(4-Bromophenyl)ethanol, 95.0%, 10g

N,N-Dimethyl-2-phenoxyethanamine, 95.0%, 10g

5-(ethoxycarbonyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid, 95.0%, 5g

Methyl 6-(benzyloxy)-5-bromopicolinate, 98%, 1g